Magnetic resonance elastography to predict liver cancer recurrence after surgery
Part of Cancer, Digestive system clinical trials.
This study looks at whether a special MRI scan after liver surgery can help predict if the cancer might come back. By measuring the stiffness of the tissue around the tumor, doctors hope to identify patients who may need closer monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have a confirmed diagnosis of liver cancer (either primary or spread from another site like the colon).
- You must be able to have surgery to remove the tumor, with the goal of curing the cancer.
- If you have primary liver cancer, your liver function must be relatively good (Child-Pugh class A or B).
- You must be able to undergo a special MRI scan (called 3D-MRE) about 1–2 weeks after surgery.
- You cannot have any metal implants or severe claustrophobia that prevent MRI, and you cannot have had prior liver surgery or a transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI technique (3D-MRE) to see if the structure of your liver tumor can predict how well you will respond to conversion therapy, which is treatment designed to shrink the tumor enough for surgery. If your tumor is likely to respond, this could help your doctor choose the best treatment plan.
This study uses a special MRI scan to measure liver stiffness before surgery to remove liver tumors. The goal is to see if this scan can help predict surgical risks and improve outcomes for patients undergoing liver surgery.
This study looks at MRI scans and tissue samples from people with colorectal cancer that has spread to the liver. The goal is to find patterns that might predict whether the cancer will come back after surgery, which could help guide future treatment.
This trial uses MRI scans to study how colorectal cancer that has spread to the liver grows. It may help doctors choose better treatments.
This trial compares a shorter MRI using a special dye to a CT scan for detecting liver cancer recurrence in people who have been cancer-free for at least two years after surgery or local treatment.
This study uses your liver MRI scans and medical information to build a tool that predicts survival after surgery for colorectal cancer that has spread to the liver. It may help doctors better understand your outlook and plan care.
Hear when a new Metastatic Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.